Font Size: a A A

Clinical And Molecular Analysis Of Hies And SCN

Posted on:2013-05-27Degree:MasterType:Thesis
Country:ChinaCandidate:X H LiFull Text:PDF
GTID:2234330374978167Subject:Academy of Pediatrics
Abstract/Summary:PDF Full Text Request
Part one:Clinical and molecular analysis of HIES due toDOCK8mutationObjective: To explore the clinical and molecular features of sevenchinese patients with antusomal recessive inherited hyper-lgE syndrome(AR-HIES).Methods: Clinical data peripheral blood, immunological fuctions,lymphocytes classification, of seven patients was analyzed, includingclinical manifestations, etiological examination, imaging stuty. PCR directsequnce analysis of DOCK8gene was performed in10unrelated Chinesefamilies. Most patients suffered from atopic dermatitis, eczema, recurrentskin virus infections, recurrent respiratory tract infections including otitismedia, mastoiditis, nasosinusitis, pneumonia and bronchitis, extremely highserum lgE level, decreaced lgM, and eosinophilia increase.Results: Two homologous deletion and two missense mutations inDOCK8gene were identified in children1-3, which are all new mutations.However,child7showed a wild type and children4,5,6are notquite identified until now becaunse the sequencing have not been finishedwhich may suitable for a new method.Conclusion: Four novel DOCK8mutations are identified in the3cases with HIES. DOCK8gene sequence analysis can confirm thediagnosis. Early diagnosis and jugding the conditions of patients willimprove the outcomes and help to decide whether hematopoietic celltransplantetion are taken in patients. Further researth is needed tounderstand how DOCK8normally function in lymphocytes and howDOCK8deficiency leads to disease. Part two:Novel ELANE Gene Mutation in a Chinese Boywith Severe Congenital NeutropeniaObjective: Severe congenital neutropenia (SCN) is a geneticallyheterogeneous syndrome associated with mutations of ELANE (ELA2),HAX1, GFI1, WAS, CSF3R or G6PC3. Mutation of the ELA2geneencoding human neutrophil elastase is the most common genetic alteration.Accordingly, ELA2genotyping should first be performed for geneticdiagnosis of SCN. Methods: A chinese male pediatric patient was admitted because ofrecurrent respiratory tract infection, digestive tract infection, cervicallymphadenitis with abscess formation, perianal abscess, skin infection andliver abscess. Eventually, he died of bacterial sepsis2month after the liveroperation.His peripheral blood showed a markedly decreased absoluteneutrophil count, and the bone marrow findings revealed early-stagematuration arrest of myelopoiesis. The patient and his parents, elder brotherwere subjected to detection of gene mutation analysis of ELA2by usingPCR based on genomic DNA.Results: Direct DNA sequencing analysis demonstrated that the patientharbored an insertion mutation in exon4of ELA2gene, resulting in5aminoacid insertion into the amino acid sequence(g.795598795599insGGACCAGCTGCCGGC; c.439440insGGACCAGCTGCCGGC; p.134135insAspGlnLeuProAla). But hisparents and elder brother were negative for it.Conclusion: We identified the first Chinese SCN case due to ELA2gene mutation genetically. Maintenance therapy with granulocytecolony-stimulating factor (G-CSF) is standard of care for SCN to prevent theoccurrence of life-threatening bacterial sepsis, but the effect depends on theresponse to G-CSF. In the case of non-responders, stem cell transplantationfrom an HLA-identical sibling is the optimal therapeutic modality.
Keywords/Search Tags:Hyper-IgE syndrome, DOCK8gene, gene mutationsevere congenital neutropenia, cyclic neutropenia, neutrophil elastase, ELA2, granulocyte colony-stimulating factor
PDF Full Text Request
Related items
Clinical Analysis Of 11 Cases With Congenital Neutropenia
Investigation The Function Of PBEF Induces Myeloid Differentiation Of CD34~+ Cells From Healthy Individuals And Patients With Severe Congenital Neutropenia
Observation Of Curative Effect Of Recombinant Human Granulocyte-Colony Stimulating Factor For Children Infection Associated Neutropenia
Rational Evaluation Of The Utilization Of Recombinant Human Granulocyte Colony Stimulating Factor In Patients With Gynecological Malignant Tumor In A Hospital
Clinical Analysis Of Recombinant Human Granulocyte Colony Stimulating Factor In The Treatment Of Breast Cancer After Chemotherapy
A Preliminary Clinical Observation On The Treatment Of Neutropenia After Chemotherapy By Scraping Guasha Along The Meridian
Clinical Value Of Primary Prevention Of 3/4 Degree Neutropenia With PEGylated Recombinant Human Granulocyte Colony-stimulating Factor In Platinum-containing Dual-drug Chemotherapy For Elderly Patients With Advanced Lung Cancer
The Effect Of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor For Primary Prevention Of Neutropenia After Chemotherapy In Ovarian Cancer
Effect Of PEGylated Recombinant Human Granulocyte Colony-stimulating Factor On Prevention Of Neutropenia After Chemotherapy For Small Cell Lung Cancer
10 Clinicaland Molecular Characteristics Of Severe Congenital Neutropenia Caused By Elane Gene Mutations And The Unique Role Of The Hepatitis Virus B X Protein On HEK 293 Cell Morphology And Cellular Change